• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » EMD Serono to open $115M life science campus in Massachusetts

EMD Serono to open $115M life science campus in Massachusetts

July 19, 2016
CenterWatch Staff

EMD Serono, known as Merck outside of the U.S. and Canada, a science and technology company, has announced plans to build a new campus in Burlington, Massachusetts, that will serve as a major hub for the North American life science business of Merck. The 280,000-square-foot facility will include a customer collaboration laboratory and training center as well as office space.

“This new and more expansive Merck campus gives us a unique, multi-use life science hub in the U.S.—one that provides our employees and customers with a sustainable and collaborative working environment,” said Udit Batra, member of the Merck executive board and CEO, Life Science. “We have a long history in Massachusetts, and as a global leader in life science, we are committed to strengthening our presence in one of the most important science and technology hubs in the world.”

The campus will serve as a premier global customer destination, housing both a customer service and call center and an M Lab Collaboration Center—a state-of-the-art, shared, exploratory environment where the company’s scientists and engineers work together with customers to help solve their toughest life science challenges. The M Lab Collaboration Center will be one of nine centers worldwide created specifically for collaboration, where hands-on training, customer experiments and application troubleshooting take place in a non-GMP environment. Other locations will include Brazil, China, France, India, Singapore and South Korea. This new enhanced M Lab center in Burlington, Massachusetts will replace the flagship M Lab at the company’s Billerica, Massachusetts facility.

“For nearly a decade, Merck has built a significant presence in Massachusetts and we are extremely pleased to support their expansion in Burlington through the MassWorks Infrastructure Program,” said Massachusetts Gov. Charlie Baker. “Building long-lasting public-private partnerships is vital to growing our economy, and the Merck campus represents significant investment and confidence in our shared future as a global life science center.”

Merck’s 850 full-time Billerica-based life science employees will relocate to the new campus when construction is complete in the second half of 2017.

The $115 million (€104 million) building will be LEED certified. The LEED (Leadership in Energy and Environmental Design) rating system is the most widely used third-party verification for green construction, certifying buildings that promote sustainability, resource conservation and human health.

The five-story, single-tenant building near Route 3 and Route 128 in Burlington is being built by The Gutierrez Company. The project includes an opportunity to expand an additional 70,000 square feet. Merck leases the property.

Merck will maintain its other North American life science hub in St. Louis, Missouri.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing